Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)
Public ClinicalTrials.gov record NCT03577899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (PANDA-1)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to evaluate the efficacy and safety of two different levels of conbercept intravitreal (IVT) injection as compared to the approved vascular endothelial growth factor (VEGF) antagonist active control, aflibercept intravitreal injection (2.0 mg/eye, Eylea®), in subjects with neovascular AMD.
Study identification
- NCT ID
- NCT03577899
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,157 participants
Conditions and interventions
Conditions
Interventions
- 0.5 mg Conbercept Intravitreal Injection Biological
- 1.0 mg Conbercept Intravitreal Injection Biological
- 2.0 mg Aflibercept Intravitreal Injection Biological
Biological
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2018 (Actual)
- Primary completion
- Sep 25, 2020 (Actual)
- Completion
- May 19, 2021 (Actual)
- Last update posted
- Jun 24, 2021
2018 – 2021
United States locations
- U.S. sites
- 63
- U.S. states
- 21
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kanghong Investigative Site | Phoenix | Arizona | 85053 | — |
| Kanghong Investigative Site | Tucson | Arizona | 85704 | — |
| Kanghong Investigative Site | Beverly Hills | California | 90211-1841 | — |
| Kanghong Investigative Site | Campbell | California | 95008 | — |
| Kanghong Investigative Site | Fullerton | California | 92835 | — |
| Kanghong Investigative Site | Glendale | California | 91203 | — |
| Kanghong Investigative Site | La Jolla | California | 92093 | — |
| Kanghong Investigative Site | Mountain View | California | 94040 | — |
| Kanghong Investigative Site | Oakland | California | 94609 | — |
| Kanghong Investigative Site | Palm Desert | California | 92211 | — |
| Kanghong Investigative Site | Palm Desert | California | 92260 | — |
| Kanghong Investigative Site | Sacramento | California | 95825 | — |
| Kanghong Investigative Site | Walnut Creek | California | 94598 | — |
| Kanghong Investigative Site | Golden | Colorado | 80401 | — |
| Kanghong Investigative Site | Fort Myers | Florida | 33907 | — |
| Kanghong Investigative Site | Fort Myers | Florida | 33912 | — |
| Kanghong Investigative Site | Jacksonville | Florida | 32224 | — |
| Kanghong Investigative Site | Lakeland | Florida | 33805 | — |
| Kanghong Investigative Site | Ocala | Florida | 34474 | — |
| Kanghong Investigative Site | Orlando | Florida | 32806 | — |
| Kanghong Investigative Site | Plantation | Florida | 33324 | — |
| Kanghong Investigative Site | Sarasota | Florida | 34239 | — |
| Kanghong Investigative Site | St. Petersburg | Florida | 33711 | — |
| Kanghong Investigative Site | Tampa | Florida | 33617 | — |
| Kanghong Investigative Site | ‘Aiea | Hawaii | 96701 | — |
| Kanghong Investigative Site | Bloomington | Illinois | 61704 | — |
| Kanghong Investigative Site | Chicago | Illinois | 60612 | — |
| Kanghong Investigative Site | Lemont | Illinois | 60439-2915 | — |
| Kanghong Investigative Site | Wichita | Kansas | 67226-3443 | — |
| Kanghong Investigative Site | Paducah | Kentucky | 42001 | — |
| Kanghong Investigative Site in MD | Hagerstown | Maryland | 21740 | — |
| Kanghong Investigative Site | Hagerstown | Maryland | 21740 | — |
| Kanghong Investigative Site | Boston | Massachusetts | 02114 | — |
| Kanghong Investigative Site | Detroit | Michigan | 48202 | — |
| Kanghong Investigator Site | Bloomfield | New Jersey | 07003 | — |
| Kanghong Investigative Site | Albany | New York | 12206 | — |
| Kanghong Investigative Site | Hauppauge | New York | 11788 | — |
| Kanghong Investigative Site | Rochester | New York | 14620-4655 | — |
| Kanghong Investigative Site | Cincinnati | Ohio | 45242 | — |
| Kanghong Investigative Site | Cleveland | Ohio | 44122-7344 | — |
| Kanghong Investigative Site | Cleveland | Ohio | 44195 | — |
| Kanghong Investigative Site | Dublin | Ohio | 43016 | — |
| Kanghong Investigative Site | Eugene | Oregon | 97401 | — |
| Kanghong Investigative Site | Philadelphia | Pennsylvania | 19107 | — |
| Kanghong Investigative Site | West Mifflin | Pennsylvania | 15122-2474 | — |
| Kanghong Investigative Site | Nashville | Tennessee | 37203-5601 | — |
| Kanghong Investigative Site | Abilene | Texas | 79606-1224 | — |
| Kanghong Investigative Site | Katy | Texas | 77494 | — |
| Kanghong Investigative Site | San Antonio | Texas | 78215 | — |
| Kanghong Investigative Site | San Antonio | Texas | 78240-1502 | — |
| Kanghong Investigative Site in TX | San Antonio | Texas | 78240 | — |
| Kanghong Investigative Site | San Antonio | Texas | 78240 | — |
| Kanghong Investigative Site | San Antonio | Texas | 78251 | — |
| Kanghong Investigator Site | Southlake | Texas | 76902 | — |
| Kanghong Investigative Site | The Woodlands | Texas | 77384 | — |
| Kanghong Investigative Site | Tyler | Texas | 75701 | — |
| Kanghong Investigative Site | Willow Park | Texas | 76087 | — |
| Kanghong Investigative Site | Lynchburg | Virginia | 24502 | — |
| Kanghong Investigative Site | Norfolk | Virginia | 23502 | — |
| Kanghong Investigative Site | Warrenton | Virginia | 20186 | — |
| Kanghong Investigative Site | Silverdale | Washington | 98383 | — |
| Kanghong Investigative Site | Spokane | Washington | 99204 | — |
| Kanghong Investigative Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 116 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03577899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03577899 live on ClinicalTrials.gov.